Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
ACTIVE_NOT_RECRUITING
Status
Conditions
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia Post Cytotoxic Therapy
- Acute Myeloid Leukemia With Multilineage Dysplasia
- Chronic Myelomonocytic Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Neoplasm
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspiration and Biopsy
- DRUG: Liposome-encapsulated Daunorubicin-Cytarabine
- DRUG: Pomalidomide
Sponsor
National Cancer Institute (NCI)